Upload
bryan-daniels
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
EMR Intercountry Workshop, December 20101 |
VP-IBD Surveillance Data, 2009VP-IBD Surveillance Data, 2009
Photo: Dr. Mary Agócs
EMR Intercountry Workshop, December 20102 |
EMR Intercountry Workshop, December 20103 |
VP-IBD and Rotavirus Global and Regional VP-IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010Laboratory Network Structure, 2010
WHO Regional Reference Laboratories
WHO Global Reference Laboratories
Global:
IBD & Rota
IBD & Rota IBD & Rota
Rota
IBD
IBD & Rota
IBD & Rota
IBDRota
Rota
Rota
IBD Rota
IBD
EMR Intercountry Workshop, December 20104 |
Countries in WHO VP-IBD Surveillance Network, by WHO Region and GAVI Eligibility, 2009
Countries in WHO VP-IBD Surveillance Network, by WHO Region and GAVI Eligibility, 2009
WHO Region
No. (%) GAVI- eligible countries
No. (%) GAVI-eligible reporting
countries
No.(%) sentinel sites
Total No.(%) reporting countries
AFR
35 (49) 19 (56) 28 (15) 21 (45) AMR 7 (10) 2 ( 6) 28 (15) 9 (19) EMR 6 (8) 4 (12) 101(53) 7 (15) EUR 8 (11) 1 ( 3) 3 (2) 1 ( 2) SEAR 8 (11) 4 (12) 8 (4) 4 ( 9)
WPR 8 (11) 4 (12) 24 (13) 5 (11)
TOTAL 72 (100) 34 (100) 192 (100) 47 (100)
34 / 47 reporting countries are GAVI-eligible= 72%
EMR Intercountry Workshop, December 20105 |
Tier 1 VP-IBD Countries: Meningitis Surveillance
Tier 1 VP-IBD Countries: Meningitis Surveillance
EMR Intercountry Workshop, December 20106 |
Tier 1: Meningitis Surveillance Data, 2008 Compared with 2009
Tier 1: Meningitis Surveillance Data, 2008 Compared with 2009
India, Philippines, and Viet Nam join the network in 2009
Year 2008 2009
WHO Region
No.(%) of countries reporting
No.(%) suspected meningitis
cases
No.(%) of countries reporting
No.(%) suspected meningitis
cases
% change in number of cases
from 2008 to 2009
AFR 22 (48) 8640 (39) 21 (45) 9634 (38) +12 AMR 8 (17) 3713 (17) 9 (19) 3743 (15) +1 EMR 9 (20) 7908 (36) 7 (15) 7787 (31) -2 EUR 1 (2) 130 (1) 1 (2) 103 (1) -21 SEAR 3 (6) 1104 (5) 4 (8) 2408 (9) +118 WPR 3 (6) 602 (3) 5 (11) 1765 (7) +193 TOTAL 46 (100) 22097 (100) 47 (100) 25440 (100) +15
AMR
AFR
EMR
SEARWPR
Percent of suspected meningitis cases with probable bacterial meningitis, by country and WHO Region, 2009.
0 10 20 30 40 50 60 70 80 90 100
CameroonSwaziland
NamibiaNiger
TanzaniaMalawi
SenegalZimbabwe
BurundiGhana
ZambiaDRCTogo
EthiopiaUgandaBurkina
Côte d'IvoireRwandaGambia
KenyaEritrea
GuatemalaParaguayHonduras
VenezuelaBolivia
PanamaEcuadorMorocco
YemenPakistan
IraqAfghanistan
SyriaSudan
UkraineNepalIndia
BangladeshSri LankaMongolia
CambodiaViet Nam
% of meningitis with probable bacterial meningitis
EUR
22
52
49
922930
Percent of probable bacterial meningitis with HI, Spn or NM identified, by country and WHO region, 2009
0 10 20 30 40 50 60 70 80 90 100
Gambia n=4BurkinaF n=29
Côte d'Ivoire n=37Tanzania n=17
DRC n=7Cameroon n=80Swaziland n=27
Niger n=151Namibia n=181
Senegal n=46Togo n=75
Uganda n=212Ethiopia n=218
Malawi n=468Kenya n=34
Zambia n=79Burundi n=10
Eritrea n=0Ghana n=9
Rwanda n=3Zimbabwe n=274
Panama n=50Paraguay n=53
Bolivia n=32Honduras n=26Guatema n=104Ecuador n=144
Venezuela n=248Sudan n=256
Morocco n=1624Iraq n=243
Pakistan n=620Afghanistan n=69
Syria n=205Yemen n=1100
Ukraine n=95Sri Lanka n=4
India n=82Nepal n=119
Banglad. n=302Mongolia n=18
Cambodia n=20Viet Nam n=327
% of probable bacterial meningitis
HI
Spn
NM
AMR
AFR
EMR
SEARWPR
EUR
EMR Intercountry Workshop, December 20109 |
% Probable Bacterial Meningitis Cases with HI, by Years of Hib Vaccine Introduction & WHO Region, 2009
(regional medians with country-specific ranges)
% Probable Bacterial Meningitis Cases with HI, by Years of Hib Vaccine Introduction & WHO Region, 2009
(regional medians with country-specific ranges)
Number of years of Hib vaccine introduction
<1 yr or Hib vaccine not in
use 1-4yrs 5+ yrs
WHO Region
No. countries with Hib
introduced
% of probable bacterial
meningitis cases with
HI
No. countries with Hib
introduced
% of probable bacterial
meningitis cases with HI
No. countries with Hib
introduced
% of probable bacterial
meningitis cases with HI
AFR* 6 14 (1-24) 7 1 (0-3) 8 0 (0-1) AMR** 0 0 1 0 8 3 (2-6) EMR 3 0 (0-4) 3 0 (0-1) 1 0 EUR 0 0 1 1 0 0 SEAR 3 6 (2-9) 1 100 0 0 WPR 3 4 (4-5)*** 2 0**** 0 0 OVERALL 15 5 15 0 17 1
*ND from Ghana
**ND from Brazil and El Salvador
***ND from the Philippines
****ND from PNG
Data collected from WHO Regions and partners and WHO/IVB Database as of September 2010 .
Invasive Bacterial Diseases Surveillance Tier 2
Invasive Bacterial Diseases Surveillance Tier 2
Slide date: 16 September 2010
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2010. All rights reserved
16 Countries
VP-IBD Surveillance: Tier 2Meningitis-Sepsis-Pneumonia Surveillance
VP-IBD Surveillance: Tier 2Meningitis-Sepsis-Pneumonia Surveillance
EMR Intercountry Workshop, December 201011 |
IBD Surveillance, Tier 2Meningitis-Sepsis-Pneumonia
IBD Surveillance, Tier 2Meningitis-Sepsis-Pneumonia
Numbers of reporting countries & children enrolled with pneumonia with % change from 2008 to 2009, by
WHO region
Numbers of reporting countries & children enrolled with pneumonia with % change from 2008 to 2009, by
WHO region
Year 2008 2009
WHO Region
No.(%) of reporting countries
No.(%) children enrolled with pneumonia
No.(%) of reporting countries
No.(%) children enrolled with pneumonia
% change in number of enrolled
from 2008 to 2009
AMR 7 (47) 11428 (72) 8 (50) 14546 (82) +27 EMR 4 (27) 1051 (7) 4 (25) 1634 (9) +55 SEAR 3 (20) 1198 (8) 3 (19) 4433 (25) +270 WPR 1 (7) 2286 (14) 1 (6) 1631(9) -29 TOTAL 15 (100) 15963 (100) 16 (100) 17811 (100) +12
SEAR: increased reporting from Bangladesh & Nepal
EMR Intercountry Workshop, December 201012 |
Tier 2: Meningitis-Pneumonia-SepsisDetected Organisms, 2009
Tier 2: Meningitis-Pneumonia-SepsisDetected Organisms, 2009
WHO Region Haemophilus
influenzae Streptococcus pneumoniae
AMR 16 (37) 96 (60) EMR 2 ( 5) 19 (12) SEAR 25 (58) 31 (19)
WPR 0 13 ( 8)
OVERALL 43 (100) 159 (100)
Percent distribution of Spn serotypes among cases of meningitis due to Spn, 2009
0 5 10 15 20 25
4 6B 9V14
18C19F23F
1 5
7F3
6A19A
2 8
9A9N
10A11A12A12F15B17F
2022F33F
4546
Sero
typ
e
% of Meningitis cases
AFR n=235 SEAR n=16
%serotypes in PCV-7, 10, and 13AFR: 48%, 80%, and 91%, SEAR: and 44%, 69%, and 75% ,
Spn. Serotype Data, Tier 1: MeningitisSpn. Serotype Data, Tier 1: Meningitis
EMR Intercountry Workshop, December 201014 |
Rotavirus Surveillance, 2009Rotavirus Surveillance, 2009
Photo: Dr. Duncan Steele
EMR Intercountry Workshop, December 201015 |
Rotavirus SurveillanceCountries Participating in the WHO Network and
Reporting Data for 2009
Rotavirus SurveillanceCountries Participating in the WHO Network and
Reporting Data for 2009
Data collected from WHO Regions.
Slide date: 2 August 2010Yes (55 Member States or 28% of Member States)
EMR Intercountry Workshop, December 201016 |
IBD and Rotavirus Global and Regional IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010Laboratory Network Structure, 2010
WHO Regional Reference Laboratories
WHO Global Reference Laboratories
Global:
IBD & Rota
IBD & Rota IBD & Rota
Rota
IBD
IBD & Rota
IBD & Rota
IBDRota
Rota
Rota
IBD Rota
IBD
EMR Intercountry Workshop, December 201017 |
Countries in the WHO Rotavirus Surveillance Network, by WHO Region & GAVI Eligibility, 2009
Countries in the WHO Rotavirus Surveillance Network, by WHO Region & GAVI Eligibility, 2009
By GAVI eligibility WHO region
No.(%) of GAVI-eligible countries
No.(%) of GAVI-eligible countries
reporting
No.(%) hospital sentinel sites
Total No.(%) of reporting countries
AFR
35 (49) 12 (34) 18 (11) 12 (22) AMR 7 (10) 4 (57) 59 (34) 14 (25) EMR 6 (8) 4 (67) 68 (40) 13 (24) EUR 8 (11) 6 (75) 9 (5) 6 (11) SEAR 8 (11) 4 (50) 4 (2) 4 (7)
WPR 8 (11) 4 (50) 13 (8) 6 (11)
TOTAL 72 (100) 34 (47) 171 (100) 55 (100)
34 / 55 are GAVI-eligible= 62%
EMR Intercountry Workshop, December 201018 |
Rotavirus Surveillance2008 Compared with 2009
Rotavirus Surveillance2008 Compared with 2009
Year 2008 2009
WHO Region
No. (%) of reporting countries
No. (%) of children enrolled
with acute diarrhoea
No. (%) of reporting countries
No. (%) of children enrolled
with acute diarrhoea
% change in number of
children enrolled from 2008 to
2009
AFR 8 (18) 3,838 (9) 12 (22) 5,071 (10) +32
AMR 9 (20) 13,761 (33) 14 (25) 16,427 (32) +19
EMR 13 (30) 14,640 (35) 13 (24) 14,477 (29) -1
EUR 5 (11) 4,801 (12) 6 (11) 6,330 (12) +32
SEAR 2 (4) 324 (1) 4 (7) 2,596 (5) +701
WPR 7 (16) 4,050 (10) 6 (11) 5,511 (11) +36
TOTAL 44 (100) 41,414 (100) 55 (100) 50,412 (100) +22
SEAR: Indonesia and Sri Lanka joined in 2009
NOTE: No data from the AMR countries of St. Vincent & Grenadines and Surinam.
EMR Intercountry Workshop, December 201019 |
% positive for rotavirus among children enrolled with acute gastroenteritis who had stool specimens tested, by country and WHO region, 2009
0 10 20 30 40 50 60 70 80
DRCZimbabwe
GhanaTogo
KenyaTanzania
ZambiaSenegalUganda
Guinea BissauCameroon
EthiopiaGuyana
HondurasGuatemala
Bolivia Paraguay
ChileEl Salvador
SurinamVenezuelaColombiaPanama
NicaraguaEcuador
St.Vincent&GrenaIran
OmanAfghanistan
YemenLibyaSyria
IraqJordan
MoroccoEgypt
PakistanTunisiaSudan
UkraineTajikistan
GeorgiaArmenia
Republic ofAzerbaijanIndonesiaMyanmar
NepalSri LankaViet Nam
LaosFiji
MongoliaChina
Papua New Guinea
% positive for rotavirus
AMR
AFR
EMR
EUR
SEAR
WPR
EMR Intercountry Workshop, December 201020 |
% Positive for Rotavirus, WHO Regional Medians and Ranges, 2009
% Positive for Rotavirus, WHO Regional Medians and Ranges, 2009
WHO region
No. (%) Reporting Countries
Median)%( Country-specific
Ranges)%(
AFR 12 (22)3515 – 59AMR 14 (25)25 0 – 52EMR 13 (24)4214 – 60EUR 6 (11)3712 – 52
SEAR 4 (7)3726 – 48WPR 6 (11)4724 – 68
TOTAL 55 (100)36 0 – 68
Countries using rotavirus vaccine: Bolivia, Colombia, Ecuador, El Salvador, Honduras, Nicaragua, Panama, Venezuela
EMR Intercountry Workshop, December 201021 |
Genotypes, 2009n=2,782Genotypes, 2009n=2,782
Global distribution of rotavirus serotypes n=21,256, 1993-2004
52.2%
11.5%2.8%
7.5%
2.3%
23.7% P[8], G1
P[4], G2
P[8], G3
P[8], G4
P[8], G9
Other
% distribution of rotavirus genotypes by country and WHO region, 2009
0% 20% 40% 60% 80% 100%
Kenya n=32
Uganda n=41
Tanzania n=31
Zambia n=40
Ethiopia n=30
Togo n=29
Zimbabwe n=30
Senegal n=70
Cameroon n=33
Guatemala n=213
El Salvador n=229
Nicaragua n=347
Sudan n=294
Azerbaijan n=86
Tajikistan n=55
Ukraine n=204
Moldova n=43
Indonesia n=195
Papua New Guinea n=12
Viet Nam n=735
% of total specimens typed
P[8], G1
P[4], G2
P[8], G3
P[8], G4
P[8], G9
uncommon
mixed
untypeable
AFR
AMR
EMR
EUR
SEAR
WPR
Countries using rotavirus vaccine: Nicaragua, El Salvador